AsadDurraniMD

Retinal Disease

Physician

Dr. Durrani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 2022 - 2024
University of Michigan Health SystemResidency, Ophthalmology, 2019 - 2022
University of Pittsburgh School of MedicineClass of 2018

PubMed

Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.
Asad F Durrani, Bita Momenaei, Viren Soni, Matthew Tennant, Jason Hsu
Journal of Ocular Pharmacology and Therapeutics. 2024-11-01
Outcomes in eyes with retained lens fragments undergoing pars plana lensectomy and scleral-fixated intraocular lens insertion.
Asad F Durrani, Bita Momenaei, Jonathan L Martin, Taku Wakabayashi, Saif A Hamdan
Retina. 2024-10-23
5 citations
Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.
Asad Farooq Durrani, Bita Momenaei, Taku Wakabayashi, Sudheshna Vemula, Saagar A Pandit
The British Journal of Ophthalmology. 2024-08-22

2023 Wills Eye Conference Presentations: Top Retina TakeawaysMarch 24th, 2023
Conducting Impactful Research as a Retina FellowMarch 2nd, 2023
Emerging Oral Pharmaceuticals for Dry Age-Related Macular Degeneration: Mechanism of Action, Current Clinical Status, and Future DirectionsJuly 1st, 2024